Medical Devices & Medicines

Own manufacturers of physical healthcare products, pairing medical-device franchises with established medicine businesses rather than healthcare insurers, service providers or research platforms. Device makers anchor the basket, distinguishing it from the fleet's drug-focused portfolios. Lilly's recent company-specific strength supports the medicines allocation, while the device businesses diversify exposure across surgery, cardiovascular care and chronic-disease management. Catalysts: - 2026-10-20 LLY: Eli Lilly shares rise 3.6% as GLP-1 franchise stays in focus (https://www.marketbeat.com/instant-alerts/price-eli-lilly-and-company-nyse-lly-shares-climb-36-still-a-buy-2026-10-20/) Launch basket (equal weight): MDT, JNJ, ABT, BSX, SYK, ISRG, DXCM, LLY, AMGN, ABBV Rules: 1. No inverse, leveraged or volatility ETFs. 2. Only names tradable at the enrolled brokers (Moomoo): no OTC listings, no dead tickers, nothing on the refused list.